The m5C modification influences cell transcription and enhances tumor cell survival via the NSUN2-YBX1-QSOX1 axis, which contributes to the intrinsic resistance of EGFR mutant NSCLC to gefitinib [218]. This evidence concerns the gene NSUN2 and neoplasm.